Related Experiment Videos
Clinical aspects of localized and systemic scleroderma
1Medical University of South Carolina, Charleston.
Current Opinion in Rheumatology
|December 1, 1991
Summary
Recent research explored potential causes of scleroderma, like tryptophan metabolism and silicone exposure, while ruling out Borrelia burgdorferi. Advances in detecting cardiac and pulmonary issues in systemic scleroderma were also highlighted.
Area of Science:
- Rheumatology
- Dermatology
- Immunology
Background:
- Recent reports suggest potential etiologic agents for localized and systemic scleroderma.
- Investigated factors include tryptophan metabolism alterations, appetite suppressant use, and silicone exposure.
- Borrelia burgdorferi was investigated as an infectious agent for localized scleroderma.
Purpose of the Study:
- To review recent findings on potential causes of scleroderma.
- To discuss the implications of Borrelia burgdorferi in localized scleroderma.
- To highlight advances in managing and evaluating systemic scleroderma complications.
Main Methods:
- Literature review of recent reports and studies.
- Analysis of findings related to potential etiologic agents.
- Evaluation of emerging data on systemic scleroderma complications.
Main Results:
- Borrelia burgdorferi was not implicated in localized scleroderma.
- Tryptophan metabolism, appetite suppressants, and silicone exposure are under investigation as potential causes.
- Improved outcomes in systemic scleroderma with renovascular hypertension were noted.
- Cardiac and pulmonary involvement in systemic scleroderma are increasingly recognized.
Conclusions:
- Scleroderma research is exploring diverse potential etiologies.
- Early detection and management of cardiac and pulmonary complications are crucial for systemic scleroderma.
- Further research is needed to elucidate the exact causes and optimize treatment strategies.